Publication of Study Results. GSK represents that it generally seeks publication of the results of all GSK-Sponsored interventional Research in peer-reviewed, searchable journals and imposes specified timeframes for the drafting and submission of manuscripts following completion of a study. For purposes of these publication requirements, GSK’s publication policy includes certain GSK-Sponsored observational Research studies and certain GSK-Sponsored meta-analyses and pooled analyses.
Publication of Study Results. Pfizer supports the exercise of academic freedom and has no objection to publication by Principal Investigator of the results of the Study based on information collected or generated by Principal Investigator, whether or not the results are favorable to the Pfizer Drug. Requirements associated with such publications are set forth in Section 15 (Publications) of the agreement between CRO and Principal Investigator.
Publication of Study Results. The Company recognizes that under the Group policy, the results of the Study must be published and agrees that researchers engaged in the Study reserve the right, and are entitled, to present and publish Data at symposia, national or regional professional meetings, and to publish in a journal or otherwise, of their own choosing, methods and results of the Study undertaken under the Agreement, subject to the requirements of this Section 3.
Publication of Study Results. 1) The full or partial results of the Study shall not be presented or published or otherwise made public by the Medical Care Institution or the Principal Investigator unless prior written Sponsor’s permission is obtained.
2) The Parties agree that the Study is part of a multicentre study and it is the intent of the parties that the first publication and/or presentation of the results of the Study will be made in conjunction with the presentation of a joint, multicentre publication of the complete multicentre study results. patentové přihlášky či nikoli), plynoucích z provádění Studie, používání Hodnoceného léčiva či Důvěrných informací (dále jen „Vynález“).
3) Učiní-li Poskytovatel, Hlavní zkoušející a/nebo spolupracující osoby jakýkoli Xxxxxxx, Poskytovatel je povinen o této skutečnosti Zadavatele neprodleně písemně informovat.
4) Poskytovatel a Hlavní zkoušející souhlasí s tím, že veškerá práva k Vynálezům jsou vlastnictvím Zadavatele a postupují tímto veškerý podíl na jakémkoli takovém Vynálezu Zadavateli a současně se zavazují, že totéž provedou autoři takového Vynálezu, a to bez jakýchkoli závazků a nároků na odměnu vyjma těch, které vyplývají z této Smlouvy.
5) Poskytovatel a Hlavní zkoušející jsou povinni poskytnout Zadavateli přiměřenou součinnost při podávání a uplatňování případných patentových přihlášek ve vztahu k Vynálezům, a to na náklady Zadavatele.
Publication of Study Results. 1) The full or partial results of the Study shall not be presented or published or otherwise made public by the Institution or the Principal Investigator unless prior written Sponsor’s permission is obtained.
2) The parties agree that the Study is part of a multicentre study and it is the intent of the Parties that the first publication and/or presentation of the results of the Study will be made in conjunction with the presentation of a joint, multicentre publication of the complete multicentre study results.
3) Being subject to Sponsor’s written consent, Institution and the Principal Investigator will not submit for publication or presentation until publication of multicentre study results prior to any of following alternatives:
a) Sponsor’s confirmation there will be no multicentre publication; or
b) eighteen (18) months after the completion of the data analysis for the entire multicentre Study.
4) The Institution and the Principal Investigator will provide a copy of the publication or presentation 45 days before submission for publication or public disclosure for Sponsor’s review.
5) If the Sponsor notifies the Institution and the Principal Investigator that it wants to file any patent applications, the Institution and/or the Principal Investigator will defer the publication, přihlášek ve vztahu k Vynálezům, a to na náklady Zadavatele.
Publication of Study Results mimo jiné, vyplněných eCRFs a jakýchkoli dalších výkazů, zpracovaných Zdravotnickým zařízením, Hlavním zkoušejícím a/nebo Výzkumným personálem v průběhu Studie, jsou výlučným vlastnictvím Zadavatele a budou sbírána, zpracována, uchovávána a hlášena podle Protokolu a příslušných právních předpisů.
Publication of Study Results. Pfizer supports the exercise of academic freedom and has no objection to publication by Principal Investigator of the results of the 15.1
Publication of Study Results. The ability to timely publish research results is a key principle of academic freedom. Accordingly, HMH clinical trial agreements must contain publication clauses which allow HMH to publish research and study data results within a reasonable amount of time after the termination of the clinical trial. However, reasonable restrictions, such as a limited period of time for sponsor review of the publication for patent protection, are permissible.
Publication of Study Results. 1) The full or partial results of the Study shall not be presented or published or otherwise made public by the Institution or the Principal Investigator unless prior written Sponsor’s permission is obtained in compliance with the terms herein.
Publication of Study Results
